Table III.
Association of clinicopathological parameters with Gsα expression.
| Gsα expression | ||||
|---|---|---|---|---|
| Clinicopathological parametera | Low | High | Total | P-value |
| Age, mean ± SD | 21.17±11.03 | 18.62±10.60 | 19.16 ± 10.50 | 0.420b |
| Gender, n (%) | 0.727c | |||
| Male | 12 (36.4) | 21 (63.6) | 33 (100.0) | |
| Female | 6 (31.6) | 13 (68.4) | 19 (100.0) | |
| Site involved, n (%) | 0.451c | |||
| Peripheral | 13 (38.2) | 21 (61.8) | 34 (100.0) | |
| Central | 5 (27.8) | 13 (72.2) | 18 (100.0) | |
| β-value, mean ± SD | 0.681±0.304 | 0.245±0.229 | 0.478 ± 0.345 | 0.001b |
| Degree of methylation, n (%) | 0.009c | |||
| Hypomethylation | 3 (17.6) | 14 (82.4) | 17 (100.0) | |
| Hypermethylation | 4 (80.0) | 1 (20.0) | 5 (100.0) | |
| Outcome, n (%) | 0.055c | |||
| Survived | 2 (13.3) | 13 (86.7) | 15 (100.0) | |
| Died | 6 (46.2) | 7 (53.8) | 13 (100.0) | |
a
Clinicopathological cases involving missing values or without available clinicopathological values were removed for statistical analyses
b
Student's t-test
c
χ2 test. Gsα, G-protein α subunit; SD, standard deviation.